Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Scott

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Blood|September 30, 2006
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnoverSelinda J Orr, Nuala M Morgan, Joanne Elliott, et al.
Oncotarget|September 12, 2015
CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent mannerRichard D A Wilkinson, Sinead M Magorrian, Rich Williams, et al.
Cancer Research|April 15, 2010
The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progressionCheryl McFarlane, Alyson A Kelvin, Michelle de la Vega, et al.
International Journal of Nanomedicine|August 24, 2012
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infectionSharif M Abdelghany, Derek J Quinn, Rebecca J Ingram, et al.
Molecular Pharmaceutics|February 9, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic ToxicityAnas Abed, Michelle K Greene, Alhareth A Alsa'd, et al.
Chemical Science|April 10, 2018
Forming next-generation antibody-nanoparticle conjugates through the oriented installation of non-engineered antibody fragmentsMichelle K Greene, Daniel A Richards, João C F Nogueira, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2019
Identification and SAR exploration of a novel series of Legumain inhibitorsSharon L Eddie, Aaron Gregson, Emma Graham, et al.
Pharmaceutical Research|August 4, 2007
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticlesChristopher J Scott, Waleed M Marouf, Derek J Quinn, et al.
Journal of Materials Chemistry. B|April 24, 2023
Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugationAdam Leach, Marie Finnegan, Mariana S Machado, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell CytotoxicityHusam Nawafleh, Nagwa Zeinelabdin, Michelle K Greene, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Blood|September 30, 2006
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnoverSelinda J Orr, Nuala M Morgan, Joanne Elliott, et al.
Oncotarget|September 12, 2015
CCL2 is transcriptionally controlled by the lysosomal protease cathepsin S in a CD74-dependent mannerRichard D A Wilkinson, Sinead M Magorrian, Rich Williams, et al.
Cancer Research|April 15, 2010
The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progressionCheryl McFarlane, Alyson A Kelvin, Michelle de la Vega, et al.
International Journal of Nanomedicine|August 24, 2012
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infectionSharif M Abdelghany, Derek J Quinn, Rebecca J Ingram, et al.
Molecular Pharmaceutics|February 9, 2024
Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic ToxicityAnas Abed, Michelle K Greene, Alhareth A Alsa'd, et al.
Chemical Science|April 10, 2018
Forming next-generation antibody-nanoparticle conjugates through the oriented installation of non-engineered antibody fragmentsMichelle K Greene, Daniel A Richards, João C F Nogueira, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2019
Identification and SAR exploration of a novel series of Legumain inhibitorsSharon L Eddie, Aaron Gregson, Emma Graham, et al.
Pharmaceutical Research|August 4, 2007
Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticlesChristopher J Scott, Waleed M Marouf, Derek J Quinn, et al.
Journal of Materials Chemistry. B|April 24, 2023
Functionalization of polymeric nanoparticles with targeting VNAR ligands using vinyl sulfone conjugationAdam Leach, Marie Finnegan, Mariana S Machado, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell CytotoxicityHusam Nawafleh, Nagwa Zeinelabdin, Michelle K Greene, et al.
Pageof 14